Early age of onset remains a key feature in the development of polysubstance use among patients treated for AUD, especially among women. Age of onset should be routinely incorporated into assessment protocols as it may help identify patients with high risks of polysubstance use, which is likely to disrupt their recovery process.
Janssen et al. (Wed,) studied this question.